Theravance Biopharma (NASDAQ: TBPH) reported Q4 EPS of ($1.23), versus ($2.02) reported last year. Revenue for the quarter came in at $3.9 million, versus $1.4 million reported last year.

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.